You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

48 Results
Guidelines and Advice
Status: Current
ID: ES 15-5
Version: 3
Nov 2023
Drug
Other Name(s): Uromitexan® (multiple brands available)
Nov 2017
Drug
Other Name(s): Oncovin® (multiple brands available)
Nov 2017
Drug
Other Name(s): Stivarga®
Nov 2023
Regimen
Intent: Palliative
Funding:
New Drug Funding Program
    Nab-Paclitaxel - Metastatic Breast Cancer
Nov 2023
Regimen
Regimen
Intent: Palliative, Adjuvant
Nov 2017
Regimen
Cancer Type:
Gynecologic, 
Germ Cell
Intent: Adjuvant
Nov 2017
Regimen
Cancer Type:
Sarcoma, 
Kaposi's Sarcoma
Intent: Palliative
Nov 2017
Regimen
Cancer Type:
Gastrointestinal, 
Esophagus, 
Gastric / Stomach
Intent: Adjuvant, Adjuvant
Nov 2017
Regimen
Cancer Type:
Sarcoma, 
Osteogenic / Bone, 
Soft Tissue
Intent: Palliative
Nov 2017
Regimen
Cancer Type:
Lung, 
Small Cell
Intent: Palliative
Nov 2023

Pages